FBRX

Forte Biosciences Inc. (FBRX) is a clinical-stage biopharmaceutical company based in Torrance, California, focused on pioneering therapeutics for skin diseases, with a particular emphasis on eczema and associated conditions. Leveraging a proprietary platform supported by cutting-edge genetic and biological research, Forte is committed to developing targeted treatment solutions aimed at improving patient outcomes in dermatology. As the company advances through clinical trials and navigates the regulatory landscape, it positions itself as a formidable player in the dermatological therapy market, presenting promising investment potential for institutional investors within the biotechnology domain.